Paragon Bioservices Appoints New CTSO, Bolsters Leadership Ranks to Support Late-Stage Clinical and Commercial Biopharmaceutical Manufacturing

Appointments and Promotions Continue to Position Paragon as Industry-Leading Gene Therapy and Vaccine CDMO Paragon Bioservices, the leading private equity-backed, biologics contract development and manufacturing organization (CDMO) announced today the appointment of Thomas VanCott, Ph.D., as Chief Technology and Strategy Officer (CTSO), along with several key promotions and new hires. “We are thrilled to welcome Tom […]

AURP Announces Brian Darmody as New CEO and Launches ‘AURP HQ2’ in Washington, DC Area

The Association of University Research Park, a professional association of university-related research and science parks, announced the appointment of Brian Darmody, Associate Vice President of Corporate Engagement at the University of Maryland (UMD), as its new Chief Executive Officer (CEO). Additionally, the association has opened a new office at the UMD Discovery District in the Washington, DC area, to […]

Indalo Therapeutics Appoints Seasoned Biopharmaceutical Executive Robert Jacks President & CEO

Indalo Therapeutics, a biopharmaceutical company discovering and developing integrin antagonists for patients suffering from serious fibrotic diseases such as nonalcoholic steatohepatitis (NASH) and idiopathic pulmonary fibrosis (IPF), today announced that Robert Jacks has been appointed President & CEO. Mr. Jacks brings to Indalo 18 years of experience in biopharmaceutical product development, corporate strategy, business development, […]

PressComm PR Client Rachel King, CoFounder and CEO, GlycoMimetics Inc. Featured on PharmaVOICE Podcast

King-Rachel-PVcom-FeaturedImage630x315-560x315

Rachel King has charted a unique career — from consultant to VC to startup to now CEO — and is leading a pioneering company in the use of glycobiology technology. Click here to listen to the podcast via Pharmavoice.com”

Popper and Company Adds Diagnostic Industry Leaders as Senior Advisors

Popper and Co., a strategy consulting and transaction advisory firm guiding medical technology and life sciences companies working on the leading-edge of diagnostics and patient management, announced today the addition of Vincent Linder, PhD and Gene Vivino to its growing team of industry and clinical senior advisors. Both Dr. Linder and Mr. Vivino provide strong industry knowledge and extensive operating […]

Welldoc Achieves Significant Digital Health Milestone by Securing Its 10th Patent for Its BlueStar Digital Therapeutic

Welldoc®, a leading digital health company, announced today that it has secured a technology patent (based on U.S. Patent Application No. 15/923,010) from the United States Patent and Trademark Office for the Software Engine Technology that powers its BlueStar® digital therapeutic. “The awarding of this tenth technology patent to Welldoc is a validation of our […]

WBJ Viewpoint Piece from BHI’s Rich Bendis and UMD’s Brian Darmody on Boosting Federal Tech Transfer

While Maryland boasts world-class universities and many private sector firms, the major reason it ranks No. 1 in the country in per capita research spending is the presence of 74 federal research laboratories, such as the National Institutes of Health. Our federal laboratories host supremely talented researchers, including Nobel Prize winners, and house some of […]

Innovative Anchor Ventures Event on “The New Fabric of Baltimore” Featured in BBJ

Why tech folks need designers: ‘If it’s not easy to wear, people won’t wear it.’ Entrepreneur Frederic Chanay has been working for seven years to design T-shirts and sports bras that are able to constantly collect biomedical data on the people wearing them. But he’s also discovered how important it is for those clothes to […]

Maryland Tech Council Appoints Marty Rosendale Chief Executive Officer

Gaithersburg, Maryland (September 19, 2018) – The Maryland Tech Council (MTC), the state’s largest trade association supporting the technology and life sciences sectors, today announced the appointment of Marty Rosendale as Chief Executive Officer (CEO), effective immediately. “Marty is a long-time member of MTC and served as senior executive advisor of the Tech Council of Maryland […]

Popper and Co. to Present New Framework for Economic Evaluation of Diagnostics in the Era of Precision Medicine at Next Generation Dx Summit

Popper and Co., a strategy consulting and transaction advisory firm serving the needs of the medical technology and life sciences industries, announced today that Co-Founder and President Caroline Popper, M.D., will speak at the 10th Annual Next Generation Dx Summit on August 22 at 5 pm ET at the Grand Hyatt Washington in Washington, DC. In the era of precision medicine, it’s more important […]

PressComm

News